Michelle T. Ashworth

Author

Also Known As

M Ashworth, M.T. Ashworth, Michelle Ashworth, Michelle T. Ashworth

Publications

411

Citations

H-Index

Concepts

All Affiliations

Michelle T. Ashworth is an author at University of California, San Francisco specializing in oncology, radiation oncology, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	115
2	Immunology	1	1	27
3	Pathology	1	1	88
4	Cancer Therapeutics	1	1	88
5	Immune Surveillance	1	1	27

Michelle T. Ashworth

Publications

310

Citations

H-Index

Page 1

	Year	Citations
Phase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid Tumors Adil Daud, Michelle T. Ashworth, Jonathan Strosberg, Journal of Clinical Oncology	2015	184
Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial Alexander M. Menzies, Michelle T. Ashworth, S. Swann, Annals of Oncology MedicineMelanomaPathologyCombined DabrafenibCancer Treatment	2014	88
Systemic antitumor effect and clinical response in a phase 2 trial of intratumoral electroporation of plasmid interleukin-12 in patients with advanced melanoma. Adil Daud, Alain P. Algazi, Michelle T. Ashworth, Journal of Clinical Oncology ImmunologyNk CellsImmunoeditingImmunotherapeuticsDermatology	2014	27
Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100) Adil Daud, Alain P. Algazi, Michelle T. Ashworth, Journal of Translational Medicine	2015	11

Page 1